2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Alters the Regulation of Pax5 in Lipopolysaccharide-Activated B Cells

BS Yoo, DR Boverhof, D Shnaider… - Toxicological …, 2004 - academic.oup.com
BS Yoo, DR Boverhof, D Shnaider, RB Crawford, TR Zacharewski, NE Kaminski
Toxicological Sciences, 2004academic.oup.com
Abstract The environmental contaminant 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD)
produces a profound suppression of the primary immunoglobulin-M (IgM) antibody
response. The suppression of IgM production by TCDD can occur through direct interactions
with the B cell, is aryl hydrocarbon receptor–dependent, and is mediated through alterations
in the differentiation of B cells into plasma cells. The objective of the present investigation
was to characterize the effects of TCDD on the regulation of Pax5, a crucial repressor of B …
Abstract
The environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) produces a profound suppression of the primary immunoglobulin-M (IgM) antibody response. The suppression of IgM production by TCDD can occur through direct interactions with the B cell, is aryl hydrocarbon receptor–dependent, and is mediated through alterations in the differentiation of B cells into plasma cells. The objective of the present investigation was to characterize the effects of TCDD on the regulation of Pax5, a crucial repressor of B-cell differentiation, and four downstream targets that are directly regulated by Pax5 and involved in immunoglobulin regulation, immunoglobulin heavy chain (IgH), kappa light chain (Igκ), J chain, and X box protein-1 (XBP-1). Lipopolysaccharide (LPS) activation of aryl hydrocarbon receptor–expressing CH12.LX cells induced B cell differentiation and robust immunoglobulin secretion that was markedly (~50%) suppressed in the presence of 10 nM TCDD. Kinetic studies show that LPS-activation induced a time-dependent decrease in Pax5 mRNA levels, protein, and DNA binding activity during a 72-h culture period that was almost completely blocked in the presence of TCDD. Concomitant with the time-dependent down-regulation of Pax5 in LPS-activated control CH12.LX cells, a reciprocal induction of IgH, Igκ, J chain mRNA levels, and cellular XBP-1 was observed. Conversely, and consistent with the absence of Pax5 down-regulation associated with TCDD treatment, IgH, Igκ, J chain mRNA, and XBP-1 protein were persistently repressed in LPS-activated CH12.LX cells. Collectively, these studies demonstrate the involvement of altered Pax5 regulation in the suppression of the primary IgM antibody response by TCDD.
Oxford University Press